[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353562-105":59,"doc-detail-353562-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comorbidity-level-and-risk-of-90-day-and-18-month-complications-among-patients-undergoing-radical-prostatectomy-for-prostate-cancer-in-the-military-health-system-abstract","Comorbidity Level and Risk of 90-day and 18-month Complications Among Patients Undergoing Radical Prostatectomy for Prostate Cancer in the Military Health System - Abstract","","The study evaluates how comorbidity level affects postoperative outcomes in men with non-metastatic prostate cancer treated with radical prostatectomy within the Military Health System. Using the MilCanEpi cohort (2001–2014) and ICD-9 diagnosis codes, it estimates adjusted risk ratios for 90-day general and genitourinary complications plus readmissions, and for 18-month genitourinary complications. Higher Elixhauser comorbidity categories show significantly elevated complication and readmission risks, motivating risk-management strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comorbidity-level-and-risk-of-90-day-and-18-month-complications-among-patients-undergoing-radical-prostatectomy-for-prostate-cancer-in-the-military-health-system-abstract/353562/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comorbidity-level-and-risk-of-90-day-and-18-month-complications-among-patients-undergoing-radical-prostatectomy-for-prostate-cancer-in-the-military-health-system-abstract/353562.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was comorbidity measured in the study?","Question",{"text":112,"@type":113},"Comorbidity was measured using the Elixhauser Index categories: 0, 1-2, or ≥3 conditions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What postoperative outcomes were assessed?",{"text":117,"@type":113},"The study assessed 90-day general and genitourinary complications and hospital readmissions, and 18-month postoperative genitourinary complications.",{"name":119,"@type":110,"acceptedAnswer":120},"What association did comorbidity level have with complications after radical prostatectomy?",{"text":121,"@type":113},"Men with higher comorbidity (especially ≥3) had statistically significantly higher risks of 90-day complications and readmissions, and both 1-2 and ≥3 comorbidity groups had higher 18-month genitourinary complication risks.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353562,1790789455,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Comorbidity Level and Risk of 90-day and 18-month Complications Among Patients Undergoing Radical Prostatectomy for Prostate Cancer in the Military Health System  \nCancer Control Volume 33: 1-14 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/10732748261420506](DOI: 10.1177/10732748261420506)  \n[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)  \nYvonne L. Eaglehouse, PhD, MPH 1,2 􀀁, Christian Dide-Agossou, PhD1,2 􀀁 , Sarah Darmon, PhD 1,2, Sean Q. Kern, MD 1, Molly R. Oroho, BS3,  \nAndrea A. Almeida, MA, MPH2,4, Craig D. Shriver, MD 1, and Kangmin Zhu, MD, PhD 1,2,5  \nAbstract  \nIntroduction: Prostate cancer is frequently diagnosed at ages when men may also have comorbidity. Access to care may inﬂuence both comorbidity management and cancer treatment and recovery. We examined the association between comorbidity and postoperative outcomes among men with prostate cancer in the universal access Military Health System (MHS) . Methods: Weidentiﬁeda cohort of men diagnosed with non-metastatic prostate adenocarcinoma from2001-2014who received radical prostatectomy (RP) within 1 year of diagnosis in the MilCanEpi database, which links the Department of War Cancer Registry and MHS Data Repository. We used ICD-9 diagnosis codes to capture 90-day postoperative general and genitourinary (GU) complications and hospital readmissions; and 18-month postoperative GU complications. Poisson regression estimated the adjusted risk ratios (ARRs) and 95% conﬁdence intervals (CIs) for the outcomes associated with comorbidity (0, 1-2, or ≥3) measured using the Elixhauser Index. Results: The study included 5645 men with non-metastatic prostate cancer (mean age 57.9 ± 7.7 years) who received RP; 39.9% of patients had no comorbidity, 43.9% had 1-2 conditions, and 16.2% had ≥3 conditions. Patients with ≥3 comorbidities had statistically signiﬁcant higher risks of 90-day general (ARR = 1.88, 95% CI = 1.34, 2.64) and GU (ARR = 1.20, 95% CI = 1.06, 1.36) complications and hospital readmission (ARR = 1.59, 95% CI = 1.12, 2.26) relative to men with no comorbidity. At 18-month post-RP, men with 1-2 comorbidities (ARR = 1.19, 95% CI = 1.05, 1.35) and ≥3 comorbidities (ARR = 1.32, 95% CI = 1.13, 1.55) had statistically signiﬁcant higher risk of measured GU complications relative to men with no comorbidity.  \nConclusions: In the MHS, higher comorbidity was associated with an increased risk of 30-day and 18-month complications and 90-day readmissions following RP for prostate cancer. This study identiﬁes a need for risk management strategies to reduce complication rates among men with higher comorbidity levels diagnosed with prostate cancer and treated by RP.  \nKeywords  \nprostate cancer, radical prostatectomy, comorbidity, complications, incontinence, erectile dysfunction  \nReceived: October 2, 2025; revised: December 19, 2025; accepted: January 14, 2026.  \n1 Department of Surgery, Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA 2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA  \n3Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA  \n4Department of Surgery, Center for Prostate Disease Research, Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA  \n5Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA  \nCorresponding Author:  \nYvonne L. Eaglehouse, PhD, MPH, Murtha Cancer Center Research Program (MCCRP), Uniformed Services University of the Health Sciences (USUHS), 6720A Rockledge Drive, Suite 310, Bethesda, MD 20817, USA.  \nEmail: [yvonne.eaglehouse.ctr@usuhs.edu](yvonne.eaglehouse.ctr@usuhs.edu)  \nCreative Commons Non Commercial CC BY-NC: This article i","cbCaiuhta5bLdnGy","https://ap.wps.com/l/cbCaiuhta5bLdnGy","pdf",960228,14,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"How was comorbidity measured in the study?\",\"answer\":\"Comorbidity was measured using the Elixhauser Index categories: 0, 1-2, or ≥3 conditions.\"},{\"question\":\"What postoperative outcomes were assessed?\",\"answer\":\"The study assessed 90-day general and genitourinary complications and hospital readmissions, and 18-month postoperative genitourinary complications.\"},{\"question\":\"What association did comorbidity level have with complications after radical prostatectomy?\",\"answer\":\"Men with higher comorbidity (especially ≥3) had statistically significantly higher risks of 90-day complications and readmissions, and both 1-2 and ≥3 comorbidity groups had higher 18-month genitourinary complication risks.\"}]","Comorbidity Level and Risk of 90-day and 18-month Complications Among Patients Undergoing Radical Prostatectomy for Prostate Cancer in the Military Health System - Abstract | PDF",1790106048,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e0d843704d52e51accfb4797862a87d.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c14abd93bef1430359d7cbefe2cc8935.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd7f64e244e2e21983ba65bd9da8cfb7.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94bb30a287a20d0d4664a99825f12144.webp",980,1268]